This inventor holds 3 USPTO granted patents and 6 published patent applications. Top assignee: Morphotek, Inc.. Active years: 2012-2017.
Location History:
- Boston, MA (US) (2012)
- Cambridge, MA (US) (2015 - 2017)
Company Filing History:
Years Active: 2012-2017
Title: Alison O'Neill: Innovator in Cancer Treatment
Introduction
Alison O'Neill is a prominent inventor based in Cambridge, MA (US), known for her significant contributions to the field of cancer treatment. With a total of 3 patents, she has focused her research on innovative methods for addressing metastatic tumors.
Latest Patents
One of her latest patents involves the treatment, inhibition, and detection of metastatic tumors. This invention outlines methods that include systemic administration of a chlorotoxin agent, which may be labeled or unlabeled. The methods aim to treat, inhibit, and detect metastases, particularly in the brain. Additionally, her work addresses the inhibition of neovascularization and the regression of newly formed vessels.
Career Highlights
Alison O'Neill is currently associated with Morphotek, Inc., where she continues to advance her research in cancer therapies. Her work has garnered attention for its potential to improve treatment outcomes for patients with metastatic cancer.
Collaborations
Throughout her career, Alison has collaborated with notable colleagues, including Douglas B Jacoby and Abdellah Sentissi, contributing to a dynamic research environment.
Conclusion
Alison O'Neill's innovative work in the treatment of metastatic tumors showcases her dedication to advancing medical science. Her patents reflect a commitment to improving patient care and outcomes in oncology.